customer service software
0

Global In Vitro Toxicology Testing Market

  • Published Date: 01 Jan 2019
  • Number of Pages: 140
  • Category: Healthcare and Medical
  • Country: Global
The global In Vitro Toxicology Testing Market was valued at USD 6.1 billion in 2016 and is projected to reach USD 15.60 billion by 2025, growing at a CAGR of 11.0% from 2017 to 2025.

In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.






Market Dynamics:
1. Market Drivers
1.1 Increasing ethical issues about animal testing
1.2 Growing stability in in-vitro technologies
1.3 Growing funds in R&D Department

2. Market Restraints
2.1 Resistance from regulatory bodies due to safety concerns and risks
2.2 Less assurance of in vivo stability after in vitro product transfer
2.3 Lack of in vitro models

Market Segmentation:
1. Global In Vitro Toxicology Testing Market, by Toxicity end point and test results:
1.1 ADME (Absorption, Distribution, Metabolism, and Excretion)
1.2 Skin Irritation, Corrosion, and Sensitization
1.3 Genotoxicity Testing
1.4 Cytotoxicity Testing
1.5 Ocular Toxicity
1.6 Organ Toxicity
1.7 Phototoxicity Testing
1.8 Dermal Toxicity
1.9 Carcinogenicity
1.10 Neurotoxicity
1.11 Other Toxicity Endpoints & Tests

2. Global In Vitro Toxicology Testing Market, by Products and Services:
2.1 Assays
2.1.1 Bacterial Toxicity Assays
2.1.2 Enzyme Toxicity Assays
2.1.3 Cell-Based Elisa and Western Blots
2.1.4 Receptor-Binding Assays
2.1.5 Tissue Culture Assays
2.1.6 Other Assays
2.2 Services
2.3 Reagents and labware

3. Global In Vitro Toxicology Testing Market, by Industry:
3.1 Pharmaceutical and Biopharmaceutical Industry
3.2 Cosmetics and Household Products Industry
3.3 Food Industry
3.4 Chemical Industry

4. Global In Vitro Toxicology Testing Market, by Method:
4.1 Cellular Assays
4.2 Biochemical Assays
4.3 EX Vivo Models

5. Global In Vitro Toxicology Testing Market, by Technology:
5.1 Cell Culture Technologies
5.2 High-Throughput Technologies
5.3 Cellular Imaging Technologies
5.4 Toxicogenomics

6. Global In Vitro Toxicology Testing Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. SGS S.A.
2. Covance, Inc. (A Part of Laboratory Corporation of America Holdings)
3. Bio-Rad Laboratories, Inc.
4. Qiagen N.V.
5. GE Healthcare
6. Eurofins Scientific Se
7. Merck KGaA
8. Thermo Fisher Scientific, Inc
9. Charles River Laboratories International, Inc.
10. Catalent, Inc.
11. Cyprotex PLC (A Subsidiary of Evotec Ag)
12. Promega Corporation
13. Gentronix Limited
14. Ascendance Biotechnology, Inc.
15. MB Research Laboratories

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY
Research study on the In Vitro Toxicology Testing Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.


Publisher Name : Verified Market Research
1 INTRODUCTION OF GLOBAL IN VITRO TOXICOLOGY TESTING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY END POINT AND TEST RESULTS
5.1 Overview
5.2 ADME (Absorption, Distribution, Metabolism, and Excretion)
5.3 Skin Irritation, Corrosion, and Sensitization
5.4 Genotoxicity Testing
5.5 Cytotoxicity Testing
5.6 Ocular Toxicity
5.7 Organ Toxicity
5.8 Phototoxicity Testing
5.9 Dermal Toxicity
5.10 Carcinogenicity
5.11 Neurotoxicity
5.12 Other Toxicity Endpoints & Tests

6 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCTS AND SERVICES
6.1 Overview
6.2 Assays
6.2.1 Bacterial Toxicity Assays
6.2.2 Enzyme Toxicity Assays
6.2.3 Cell-Based Elisa and Western Blots
6.2.4 Receptor-Binding Assays
6.2.5 Tissue Culture Assays
6.2.6 Other Assays
6.3 Services
6.4 Reagents and labware

7 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
7.1 Overview
7.2 Pharmaceutical and Biopharmaceutical Industry
7.3 Cosmetics and Household Products Industry
7.4 Food Industry
7.5 Chemical Industry

8 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
8.1 Overview
8.2 Cellular Assays
8.3 Biochemical Assays
8.4 EX Vivo Models

9 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
9.1 Overview
9.2 Cell Culture Technologies
9.3 High-Throughput Technologies
9.4 Cellular Imaging Technologies
9.5 Toxicogenomics

10 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the World Regional Market Estimates and Forecasts, 2012 2025

11 GLOBAL IN VITRO TOXICOLOGY TESTING MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES
12.1 SGS S.A.
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments

12.2 Covance, Inc.
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments

12.3 Bio-Rad Laboratories, Inc
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments

12.4 Qiagen N.V.
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments

12.5 GE Healthcare
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments

12.6 Eurofins Scientific SE
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments

12.7 Merck KGaA
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments

12.8 Thermo Fisher Scientific, Inc
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments

12.9 Charles River Laboratories International
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments

12.10 Catalent, Inc.
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments

12.11 Cyprotex PLC
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments

12.12 Promega Corporation
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments

12.13 Gentronix Limited
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments

12.14 Ascendance Biotechnology, Inc.
12.14.1 Overview
12.14.2 Financial Performance
12.14.3 Product Outlook
12.14.4 Key Developments

12.15 MB Research Laboratories
12.15.1 Overview
12.15.2 Financial Performance
12.15.3 Product Outlook
12.15.4 Key Developments

13 Appendix
13.1 Related Reports

The global market size of Toltrazuil is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of

View Report

The global market size of Iron Sucrose is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end

View Report

The global market size of Aminethronii Hydrobromidum is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports